DESIGN THERAPEUTICS INC (DSGN:NASDAQ)
$10.97 0.44 (4.1785%)
Analysed DESIGN THERAPEUTICS INC (DSGN:NASDAQ) News Sources
Design Therapeutics Inc (DSGN) Q1 2026 Earnings Call Highlights: Promising Progress in ...
29-04-2026
yahoo.com
Design Therapeutics, Inc. (DSGN) Is Up 6.92% in One Week: What You Should Know
11-05-2026
yahoo.com
Jim Cramer on Design Therapeutics: “Pure Spec, Pure Spec”
17-05-2026
yahoo.com
Design Therapeutics to Host Investor Webcast to Review Data from RESTORE-FA Trial of DT-216P2 for Friedreich’s Ataxia on Monday, May 18, 2026
17-05-2026
yahoo.com
Design Therapeutics Announces Four-Week IV Data from the RESTORE-FA Trial of DT-216P2 Demonstrating Clinical Improvements and Comprehensive Biomarker Activity in Friedreich Ataxia
18-05-2026
yahoo.com
Design Therapeutics Shares Jump on Encouraging Friedreich Ataxia Trial Results (DSGN)
18-05-2026
advfn.com
This Biotech Leader Ran Up As Much As 18% — And Then Lost It All
18-05-2026
yahoo.com
Design Therapeutics to Participate in 2026 Jefferies Global Healthcare Conference
28-05-2026
yahoo.com
Protego Biopharma Appoints Jae B. Kim, MD, as Chief Medical Officer
08-06-2026
yahoo.com
Are Medical Stocks Lagging Atea Pharmaceuticals (AVIR) This Year?
09-06-2026
yahoo.com
What is the current price of DESIGN THERAPEUTICS INC (DSGN:NASDAQ)?
The current price of DESIGN THERAPEUTICS INC (DSGN:NASDAQ) is $10.97.
DESIGN THERAPEUTICS INC (DSGN:NASDAQ) absolute price change since previous trading day?
The absolute price change of DESIGN THERAPEUTICS INC (DSGN:NASDAQ) since the previous trading day is $0.44.
DESIGN THERAPEUTICS INC (DSGN:NASDAQ) percentage price change since previous trading day?
The percentage price change of DESIGN THERAPEUTICS INC (DSGN:NASDAQ) since the previous trading day is 4.1785%.
What is the most recent average sentiment score for DESIGN THERAPEUTICS INC (DSGN:NASDAQ)?
The most recent average sentiment score for DESIGN THERAPEUTICS INC (DSGN:NASDAQ) is 69 out of 100.
What is the most recent average sentiment for DESIGN THERAPEUTICS INC (DSGN:NASDAQ)?
The most recent sentiment for DESIGN THERAPEUTICS INC (DSGN:NASDAQ) is .
SEC-8K** Filing Available For DESIGN THERAPEUTICS INC (DSGN:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.